Dupont Capital Management’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Dupont Capital Management’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-716	Closed	-$525K	–	639
2015 Q1	$525K	Hold	716	–	–	0.01%	507
2014 Q4	$569K	Sell	716 -634	-47%	-$341K	0.01%	533
2014 Q3	$539K	Buy	1,350 +354	+36%	+$94.8K	0.01%	551
2014 Q2	$269K	Hold	996	–	–	﹤0.01%	616
2014 Q1	$217K	Hold	996	–	–	﹤0.01%	609
2013 Q4	$269K	Buy	+996	New	+$237K	﹤0.01%	580

Other funds holding TTPH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Dupont Capital Management's TTPH Position: Q2 2015 in Review

Dupont Capital Management sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q2 2015, closing a stake of 716 shares — an estimated $525K sold.

Dupont Capital Management first reported a position in TTPH in Q4 2013 and held it in 6 quarters. The position peaked at $569K in Q4 2014. 139 funds tracked by Wall St. Rank hold TTPH as of Q2 2015.

Dupont Capital Management reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q2 2015 after selling out during the quarter.
Dupont Capital Management sold 716 Tetraphase Pharmaceuticals, Inc. shares in Q2 2015, an estimated $525K.
Dupont Capital Management first reported a position in Tetraphase Pharmaceuticals, Inc. in Q4 2013 and held it in 6 quarters.
Dupont Capital Management's Tetraphase Pharmaceuticals, Inc. position peaked at $569K in Q4 2014.
139 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q2 2015.

Based on Dupont Capital Management's 13F filing for Q2 2015, filed 3 Aug 2015.